Skip to content
Medical Health Aged Care

RACGP commends ‘smart investment’ to support rural and regional GPs in Tasmania

Royal Australian College of GPs 3 mins read

The Royal Australian College of GPs (RACGP) has welcomed Tasmanian Liberals’ commitment to attract more GPs to rural and regional areas and support to help patients receive much-needed care.

The Tasmanian Liberals announced that if re-elected, they would pay up to $100,000 of HECS student debt for up to 40 GPs who work in the state’s rural and regional areas for at least five years, fund a rapid response team of 10 GPs to be deployed to local practices as needed, and provide multi-year funding of up to $250,000 annually as flexible grants to sustain general practices.

RACGP Tasmania Chair and Launceston GP, Dr Toby Gardner welcomed the commitment to a stronger general practice workforce, but cautioned that the challenge of GP access in rural and regional areas will remain a challenge.

“With increasing costs to study medicine, the potential of a lower HECS balance is a strong draw for young doctors who are thinking about specialist GP training,” he said.

“Multi-year funding to grow our practice teams, attract GPs, improve our practices, or stay open for longer is also welcome. We have seen that funding gets results in general practice, and the Tasmanian Liberals’ commitment to general practice care is something other states and territories should consider as a model. Strong general practices keep people out of hospital, where costs to government are significantly higher. It’s a smart investment, and helps patients lead healthier, happier lives.

“We do need to bear in mind that the GPs who take part in the rapid response team will have to come from somewhere. We’ve seen the challenges our practices, and especially our rural and remote practices, have had in getting the GPs they need. The incentive of a lower HECS debt to pay off is a strong incentive for many young GPs, but we need to ensure we have a sustainable profession into the future.

“Attracting more junior doctors into the profession is vital. But we need to ensure there is the necessary ongoing Medicare funding there to keep rural and regional practices viable and accessible for their patients. We also need to ensure, as with any new approach, that the implementation and outcomes match the intention. The best way to do that is with continued consultation with GPs.

“We look forward to working with Tasmania’s next government to implement their agenda. As GPs, we want a strong primary healthcare system and we’re the ones best placed to make sure policies work in practice.”

Dr Gardner also welcomed the party’s commitment to amend the Poisons Act to allow GPs to prescribe stimulants independently for patients with ADHD and fund two GPs with a special interest in attention-deficit/hyperactivity disorder (ADHD).

“This is a really important area where Tasmanians have said they need support,” Dr Gardner said.

“While we await further detail, we have said that GPs are ready to step up to help patients and their families with ADHD. It’s an area where GPs already give our patients a lot of support, and the ability to make access to medication less complex, expensive, and stressful for patients who need it is something we strongly support.

“At the moment there are too many barriers to treatment, especially in rural and regional areas. Getting appointments with specialists is a challenge, and the cost of these appointments. GPs As the federal Barriers to consistent, timely and best practice assessment of ADHD inquiry report said, GPs can make ADHD treatment far more accessible for our patients, from diagnosis to medication management.”


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit To unsubscribe from RACGP media releases, click here.

Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699

Follow us on Twitter: @RACGP and Facebook.


More from this category

  • Medical Health Aged Care, Science
  • 17/07/2024
  • 14:00
De Motu Cordis

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Brisbane, QLD – 17 July 2024 – De Motu Cordis (DMC) today announced plans for the next stage of development with its Contract Development and Manufacturing Organization (CDMO) partner, Catalent, at Catalent’s Boston, Morrisville and San Diego sites. These expansion plans encompass services from drug product manufacturing and device assembly through to commercial launch of DMC’s product, DMC-IH1. DMC-IH1 is an inhaled epinephrine drug-device combination product being developed for the treatment of anaphylaxis using a dry powder inhaler (DPI). Catalent DPI drug delivery services offer end-to-end solutions to bring customers through the entire clinical pharma journey by leveraging the commercial…

  • Medical Health Aged Care, Women
  • 17/07/2024
  • 07:00
Monash University

Study underlines the importance of supporting primary care clinicians to deliver early medical abortion and long acting reversible contraception

The impetus for additional support and training for clinicians wanting to deliver important sexual and reproductive services has received a boost with the release of Monash University-led research. Published in BMJ – Sexual and Reproductive Health, the AusCAPPS study found that GPs, nurses and pharmacists seek peer support and online resources to deliver long-acting reversible contraception (LARC) and early medical abortion (EMA) in Australian primary care.Experienced and emerging providers of LARC and EMA sought support regarding clinical issues online from AusCAPPS, which is the Australian Contraception and Abortion Primary Care Practitioner Support Network, an evidence-based virtual community of practice launched…

  • Medical Health Aged Care
  • 17/07/2024
  • 03:11
Interrad Medical, Inc.

Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study

PLYMOUTH, Minn.–BUSINESS WIRE– Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.